Add time:08/01/2019         Source:sciencedirect.com

IntroductionIn this study, we describe development of a true matched-pair theranostic agent that is able to target the αVβ3 integrin and the gastrin releasing peptide receptor (GRPR). We herein describe methods to metallate and characterize the new conjugate and to validate its biological efficacy by in vitro and in vivo methods.

We also recommend Trading Suppliers and Manufacturers of PHE-LEU-GLU-GLU-VAL AMMONIUM (cas 104180-33-8). Pls Click Website Link as below: cas 104180-33-8 suppliers